- Updates on Treatments for Pulmonary FibrosisMarch 22, 2024
In this webinar, Professor Dan Chambers provides an overview of the current treatment options for Pulmonary Fibrosis (PF), as well as an insight into the latest advancements and breakthroughs emerging from clinical trials, offering a glimpse into the promising future of PF treatments.
- Accelerating translational research to find cure for IPF: Can we REMAP-ILD?November 11, 2022
This webinar educated health professionals about a Randomised, Embedded, Multifactorial, Adaptive, Platform (REMAP) trial design for interstitial lung disease (ILD).
- Pragmatic trials and registry/EMR-based studiesSeptember 16, 2022
This webinar educated health professionals about pragmatic clinical trials and registry/electronic medical record-based studies. Learn from an international expert about testing treatments in the real world and harnessing the power of real-world data.
- ATS 2022 Pulmonary Fibrosis in a Nutshell – What’s the latest in PF clinical research?June 3, 2022
This webinar allowed health professionals to catch up on the latest in clinical research in pulmonary fibrosis from the May 2022 ATS conference.
- Planning for implementation using science and strategySeptember 9, 2021
This webinar educated health professionals about the science and strategy of implementation in the context of clinical trials, including insights on planning for future implementation. Implementation is increasingly a focus of funding schemes, meaning that it’s a useful topic for clinical trialists and/or clinician-researchers in pulmonary fibrosis to upskill on!
- ATS 2021 – What’s the latest in pulmonary fibrosis clinical research?June 11, 2021
This webinar caught health professionals up on the latest in clinical research in pulmonary fibrosis from the May 2021 ATS conference.
- New drugs for pulmonary fibrosis – are there any blockbusters around the corner?March 30, 2021
This webinar caught health professionals up on the latest in drug development and clinical trials in pulmonary fibrosis.
Topic:
Type: